Active	Status	Sponsor type	Region	Phase	Filter
2 Active 14 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Margel, David
NCT04182594: Cardiovascular Events in GnRH Agonist vs. Antagonist	Not yet recruiting	2	80	RoW	Degarelix, Firmagon, GnRH agonist	Rabin Medical Center, Ferring Pharmaceuticals	Hormone Sensitive Prostate Cancer, Prostate Cancer, Cardiac Event	01/23	01/23
Baniel, Jack
NCT04182594: Cardiovascular Events in GnRH Agonist vs. Antagonist	Not yet recruiting	2	80	RoW	Degarelix, Firmagon, GnRH agonist	Rabin Medical Center, Ferring Pharmaceuticals	Hormone Sensitive Prostate Cancer, Prostate Cancer, Cardiac Event	01/23	01/23
Konichevky, Miriam
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Margel, David
NCT04182594: Cardiovascular Events in GnRH Agonist vs. Antagonist	Not yet recruiting	2	80	RoW	Degarelix, Firmagon, GnRH agonist	Rabin Medical Center, Ferring Pharmaceuticals	Hormone Sensitive Prostate Cancer, Prostate Cancer, Cardiac Event	01/23	01/23
Baniel, Jack
NCT04182594: Cardiovascular Events in GnRH Agonist vs. Antagonist	Not yet recruiting	2	80	RoW	Degarelix, Firmagon, GnRH agonist	Rabin Medical Center, Ferring Pharmaceuticals	Hormone Sensitive Prostate Cancer, Prostate Cancer, Cardiac Event	01/23	01/23
Konichevky, Miriam
No trials found